SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023
SANUWAVE is Pleased to Announce Preliminary Revenues of $4.7 Million to $4.9 Million for the Third Quarter Ended September 30, 2023
Results Indicate 13-18% Growth Rate Over Q3 2022
Related news for (SNWV)
- Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
- Sanuwave Health Selected for Inclusion in Russell 2000® Index
- Sanuwave Health Appoints Greg Bazar to Board of Directors
- SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)
- Sanuwave Health to Uplist to the Nasdaq Global Market